1. sanofi-aventis (2007) LANTUS (insulin glargine [rDNA origin] injection). Available from http://products.sanofi-aventis.us/lantus/lantus.pdf , accessed 15 May 2009
2. Lawson DH (2002). Insulin glargine (Lantus): Summary of recommendation. Available from www.scottishmedicines.org.uk/smc/files/Insuline%20Glargine%20FINAL.pdf , accessed 15 May 2009
3. National Institute for Clinical Excellence (2002) Guidance on the use of long-acting insulin analogues for the treatment of diabetes insulin glargine. Available from www.nice.org.uk/nicemedia/pdf/53_Insulin_analogues_full_guidance.pdf , accessed 15 May 2009
4. National Collaborating Centre for Chronic Conditions (2008) Type 2 diabetes: national clinical guideline for management in primary and secondary care (update). Available from www.nice.org.uk/nicemedia/pdf/CG66diabetesfullguideline.pdf , accessed 15 May 2009
5. National Institute for Health and Clinical Excellence (2009) NICE implementation uptake report: insulin glargine for diabetes (types 1 and 2). Available from www.nice.org.uk/media/7B3/7C/IMPUptakeReportTA53CG66GlarginevFinal.pdf , accessed 15 May 2009